| Analysis | Samples | Factors | Units |
|---|---|---|---|
| Reversed phase POSITIVE ION MODE | ms5862-10 | Time point:Post Run | Grouping:RUN-Naproxcinod | pmol/mg |
| Reversed phase POSITIVE ION MODE | ms5862-6 | Time point:Post Run | Grouping:RUN-Naproxcinod | pmol/mg |
| Reversed phase POSITIVE ION MODE | ms5862-7 | Time point:Post Run | Grouping:RUN-Naproxcinod | pmol/mg |
| Reversed phase POSITIVE ION MODE | ms5862-8 | Time point:Post Run | Grouping:RUN-Naproxcinod | pmol/mg |
| Reversed phase POSITIVE ION MODE | ms5862-9 | Time point:Post Run | Grouping:RUN-Naproxcinod | pmol/mg |
| Reversed phase POSITIVE ION MODE | ms5862-16 | Time point:Post Run | Grouping:RUN-Naproxen | pmol/mg |
| Reversed phase POSITIVE ION MODE | ms5862-17 | Time point:Post Run | Grouping:RUN-Naproxen | pmol/mg |
| Reversed phase POSITIVE ION MODE | ms5862-18 | Time point:Post Run | Grouping:RUN-Naproxen | pmol/mg |
| Reversed phase POSITIVE ION MODE | ms5862-19 | Time point:Post Run | Grouping:RUN-Naproxen | pmol/mg |
| Reversed phase POSITIVE ION MODE | ms5862-20 | Time point:Post Run | Grouping:RUN-Naproxen | pmol/mg |
| Reversed phase POSITIVE ION MODE | ms5862-26 | Time point:Post Run | Grouping:RUN-Vehicle | pmol/mg |
| Reversed phase POSITIVE ION MODE | ms5862-27 | Time point:Post Run | Grouping:RUN-Vehicle | pmol/mg |
| Reversed phase POSITIVE ION MODE | ms5862-28 | Time point:Post Run | Grouping:RUN-Vehicle | pmol/mg |
| Reversed phase POSITIVE ION MODE | ms5862-29 | Time point:Post Run | Grouping:RUN-Vehicle | pmol/mg |
| Reversed phase POSITIVE ION MODE | ms5862-30 | Time point:Post Run | Grouping:RUN-Vehicle | pmol/mg |
| Reversed phase POSITIVE ION MODE | ms5862-1 | Time point:Sedentary | Grouping:SED-Naproxcinod | pmol/mg |
| Reversed phase POSITIVE ION MODE | ms5862-2 | Time point:Sedentary | Grouping:SED-Naproxcinod | pmol/mg |
| Reversed phase POSITIVE ION MODE | ms5862-3 | Time point:Sedentary | Grouping:SED-Naproxcinod | pmol/mg |
| Reversed phase POSITIVE ION MODE | ms5862-4 | Time point:Sedentary | Grouping:SED-Naproxcinod | pmol/mg |
| Reversed phase POSITIVE ION MODE | ms5862-5 | Time point:Sedentary | Grouping:SED-Naproxcinod | pmol/mg |
| Reversed phase POSITIVE ION MODE | ms5862-11 | Time point:Sedentary | Grouping:SED-Naproxen | pmol/mg |
| Reversed phase POSITIVE ION MODE | ms5862-12 | Time point:Sedentary | Grouping:SED-Naproxen | pmol/mg |
| Reversed phase POSITIVE ION MODE | ms5862-13 | Time point:Sedentary | Grouping:SED-Naproxen | pmol/mg |
| Reversed phase POSITIVE ION MODE | ms5862-14 | Time point:Sedentary | Grouping:SED-Naproxen | pmol/mg |
| Reversed phase POSITIVE ION MODE | ms5862-15 | Time point:Sedentary | Grouping:SED-Naproxen | pmol/mg |
| Reversed phase POSITIVE ION MODE | ms5862-21 | Time point:Sedentary | Grouping:SED-Vehicle | pmol/mg |
| Reversed phase POSITIVE ION MODE | ms5862-22 | Time point:Sedentary | Grouping:SED-Vehicle | pmol/mg |
| Reversed phase POSITIVE ION MODE | ms5862-23 | Time point:Sedentary | Grouping:SED-Vehicle | pmol/mg |
| Reversed phase POSITIVE ION MODE | ms5862-24 | Time point:Sedentary | Grouping:SED-Vehicle | pmol/mg |
| Reversed phase POSITIVE ION MODE | ms5862-25 | Time point:Sedentary | Grouping:SED-Vehicle | pmol/mg |
Return to study ST000648 main page
Download data matrix(Effects of NO Donor Therapy on the Dystrophic Mouse Muscle Amino Acids (part IV) Reversed phase POSITIVE ION MODE)
- Metabolomics Workbench
|